Physician

Ivan Jose Suner, M.D.

According to 2025 Medicare claims, Ivan Suner, M.D. (NPI: 1164522793) practices ophthalmology in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF FLORIDA, P.A. (NPI: 1811959570; TIN: 592695288) and primary practice location at 33609-4614.

Suner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,003 traditional Medicare patients, billed 59,507 HCPCS/CPT codes, and received $2,215,333 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 504 prescription claims across 133 beneficiaries totaling $51,049 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 165 records totaling $324,198. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $27,130 to $51,049. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.5M2015 Medicare payment: $2,599,156 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,640,712 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,520,740 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,420,412 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,206,110 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,945,595 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,661,334 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,225,671 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,453,234 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,215,333 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201583510,692$2,599,156
201685011,183$2,640,712
20171,09715,123$3,520,740
20181,11615,688$3,420,412
20191,13914,647$3,206,110
20201,03513,594$2,945,595
20211,07512,796$2,661,334
20221,05115,898$2,225,671
20231,03957,197$2,453,234
20241,00359,507$2,215,333

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$26K$51K2015 Drug cost: $27,130 (USD; Tot_Drug_Cst)2016 Drug cost: $30,447 (USD; Tot_Drug_Cst)2017 Drug cost: $38,279 (USD; Tot_Drug_Cst)2018 Drug cost: $35,675 (USD; Tot_Drug_Cst)2019 Drug cost: $41,272 (USD; Tot_Drug_Cst)2020 Drug cost: $42,307 (USD; Tot_Drug_Cst)2021 Drug cost: $39,305 (USD; Tot_Drug_Cst)2022 Drug cost: $35,024 (USD; Tot_Drug_Cst)2023 Drug cost: $48,629 (USD; Tot_Drug_Cst)2024 Drug cost: $51,049 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201580217$27,130
201689243$30,447
2017104322$38,279
2018103314$35,675
2019116438$41,272
2020143464$42,307
2021140430$39,305
2022127399$35,024
2023121420$48,629
2024133504$51,049

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3621,139$96
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more247372$86
92014Established patient complete exam of visual system596865$81
92134Imaging of retina9331,659$29
J2777Injection, faricimab-svoa, 0.1 mg23652,620$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost301,400$10,716
Prednisolone AcetatePrednisolone Acetate973,767$3,924
DifluprednateDifluprednate16563$1,696
MoxifloxacinMoxifloxacin Hcl62983$1,359
Atropine SulfateAtropine Sulfate271,450$902

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.92$55,616Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.73$268,581Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ivan Jose Suner, M.D.?

Tedicare shows public-source Medicare data for Ivan Jose Suner, M.D. (NPI 1164522793), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ivan Jose Suner, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ivan Jose Suner, M.D.?

Ivan Jose Suner, M.D. is linked to RETINA ASSOCIATES OF FLORIDA, P.A. (billing NPI 1811959570) in the available physician profile data.

Does Ivan Jose Suner, M.D. have Open Payments data?

Ivan Jose Suner, M.D. has 165 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.